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1.1. Tankyrase 1 inhibitors from a DNA-encoded chemical library
DNA-encoded chemistry has been investigated by many groups
as an efﬁcient way to make and screen large and diverse libraries.
The presence of covalently bound DNA sequences that act as bar-
codes, encoding for the attached small molecule, simpliﬁes the
process of ascertaining the identity of active molecules in the
library. Many DNA-encoded libraries contain at least three diver-
sity positions leading to molecules that are generally larger than
more conventional ‘rule of ﬁve’ compliant molecules, possessing
molecular weights above 500 Da, and consequently are less likely
to exhibit good drug-like properties. A recent publication describes
the use of a DNA-encoded library approach to making drug-like
compounds and used for the identiﬁcation of inhibitors of the
potential pharmaceutical target, tankyrase 1 (TNKS1) [1].
The library described was comprised of two components: 121
amines paired with 630 carboxylic acids giving rise to a ﬁnal
library size of 76,230 encoded compounds. Greater than 99% of
the library had MW below 500 Da, and 89% were below 400 Da.
Furthermore, calculations suggest that 96% had ClogP values (a cal-
culated measure of lipophilicity) below 5.
The compounds were prepared using a two-step split and pool
procedure. Initially amino-modiﬁed oligonucleotides on solid sup-
port were derivitised with chloroacetic acid, before the addition of
amine-containing building blocks. Following cleavage from the
solid support and puriﬁcation, the materials were combined and
then split into separate vessels for reaction with carboxylic acid
building blocks. The addition of individual building blocks was
encoded using a DNA library protocol that has previously been
described, and the end product (1) was a library of over 76,000
compounds where there was a one-to-one correlation between










E-mail: nterrett@ensembletx.comThe library was initially screened in an afﬁnity selection format
against streptavidin and carbonic anhydrase IX, but attention then
shifted to TNKS1. TNKS1 is a poly(ADP-ribose) polymerase (PARP)
which is responsible for the modiﬁcation of proteins with
poly(ADP-ribose) chains. The enzyme has been identiﬁed as a
potential drug target, as it is involved in telomere maintenance,
and has been considered a druggable component of the Wnt
signalling pathway. Some reports have described that TNKS1
inhibitors can suppress tumour growth in animal models.
Screening the library of DNA-encoded compounds against
TNKS1 revealed a family of structurally related binders. The hit
compounds all contained one particular carboxylic acid building
block in combination with a number of different amine building
blocks. The dioxotetrahydropyrimidine benzoic acid had previ-
ously been found to be an important component of binding to






















To conﬁrm the activity of these library hits, the individual com-
pounds were resynthesised using conventional methods, now omit-
ting the acetamido group used previously to link the compounds to
the DNA tag. Activity was measured in an in vitro PARylation assay
using the catalytic domain from TNKS1. All of the compounds were
found to be potent inhibitors with IC50 values between 250 (com-
pound 2) and 700 nM (compound 3). Overall the inhibitory activity
of the compounds correlated with the sequence counts observed in
the DNA-encoded library screen.
Key compounds were proﬁled for their afﬁnity for related PARP
enzymes, revealing generally good selectivity for TNKS1, although
some compounds revealed similar inhibitory afﬁnity for TNKS2.
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coded small molecule libraries for the discovery of novel enzyme
inhibitors with scope for further modiﬁcation.2. A summary of the papers in this month’s issue
2.1. Polymer supported synthesis
The Fmoc-based solid phase synthesis of unprotected x-aspar-
tic thioacid containing peptides has been demonstrated. The
method involved the novel use of a silyl ester as a carboxylate sur-
rogate for mild peptide bond formation in the presence of a reac-
tive x-aspartyl thioester. The resulting peptide thioacids can be
used in N-glycoligation and other thioacid-mediated conjugation
reactions [2].
2.2. Solution-phase synthesis
A range of functionalised spirooxindole derivatives have been
assembled via the Diels–Alder (DA) reaction. Rongalite has been
used to generate the key sultine building blocks which represent
useful latent diene equivalents for the DA chemistry. The di-bromo
intermediates used are produced by reacting the 1,2,4,5-te-
trakis(bromomethyl)benzene with protected oxindole derivatives
under operationally simple reaction conditions [3].
Palladium-catalysed direct dehydrogenative annulation of imi-
dazo[1,2-a]pyridines with diarylalkynes through dual cleavage of
C–H bonds has been reported. This new strategy offers a straight-
forward route for the synthesis of p-conjugated polyaromatic hete-
rocycles from readily accessible imidazo[1,2-a]pyridine. An array
of 2,3,4-triarylphenyl-1,7b-diaza-cyclopenta[cd]indene derivatives
with broad functionalities have been obtained in high yields by this
protocol [4].
New bis(indolyl)methane-based heterocycles have been devel-
oped by a proﬁcient sequential synthesis in one pot, where substi-
tuted aromatic aldehydes and isocyanides were varied, producing a
library of benzamide and benzoate analogues with multiple points
of diversity. The synthesised analogues were tested for their
antibacterial potency against gram positive and gram negative
pathogenic bacteria [5].
Dihydrochalcones and 5-deoxyﬂavones are types of compounds
possessing various biologically interesting properties. The concise
and divergent total syntheses of several naturally occurring dihy-
drochalcones and 5-deoxyﬂavones from readily available starting
materials has been described. The divergent strategy is based
around manipulation of a common chalcone scaffold and features
application of Algar–Flynn–Oyamada oxidation and benzoquinone
C–H activation methodologies. This work provides an illustration
of the utility of divergent synthesis for the expedient and step-eco-
nomical preparation of natural product libraries [6].
A Michael-Michael-acetalisation cascade between 4-(2-hydrox-
yphenyl)but-3-en-2-ones and a,b-unsaturated aldehydes via a
novel dual activation mode promoted by pyrrolidine has been
successfully established. Various novel tetrahydro-6-hydroxyl-
6H-benzo[c]chromen-9-one derivatives have been prepared in
excellent diastereoselectivities and moderate to good yields.
Further diverse modiﬁcations of the resulting tricyclic scaffolds
has provided a facile pathway to achieve a variety of tetrahydro-
6-hydroxyl-6H-benzo[c]chromen-9-one analogues [7].
2.3. Scaffolds and synthons for combinatorial libraries
Molecular structure calculations indicated that the dibenzosilole
skeleton could be readily superposed on phenanthridinone, a
structural component of ligands of retinoic acid receptor-relatedorphan receptors (RORs). Consequently, a series of novel ROR
ligands based on the dibenzosilole scaffold have been designed,
synthesised and biologically evaluated. Dibenzosilole derivatives
bearing a hexaﬂuoro-2-hydroxypropyl group on the benzene ring
exhibited signiﬁcant ROR-inhibitory activity, comparable to that
of the lead phenanthridinone derivative, indicating that the
dibenzosilole skeleton would be a useful scaffold for developing
novel biologically active compounds [8].
The interest in pyridopyrimidine cores for pharmaceutical prod-
ucts in various areas of medicine, including anticancer, CNS, fungi-
cidal, antiviral, anti-inﬂammatory, antimicrobial, and antibacterial
therapies, makes this scaffold a highly useful building block for
organic chemistry. A recently published review mainly focuses
on the progress achieved since 2004 in the chemistry and biologi-
cal activity of pyridopyrimidines [9].
2.4. Solid-phase supported reagents
A convenient synthesis of 2-arylpyrroles from the catalytic
dehydrogenation of 2-aryl-1-pyrrolines in the presence of com-
mercial palladium-supported on alumina (Pd/Al2O3) has been
described. The reaction scope has been explored for aryl sub-
stituents with different steric hindrances and electronic natures,
and the reaction conditions such as temperature, reﬂux time and
amount of catalyst, were revealed to be highly dependent on the
2-aryl substituent group. Moderate to high yields and selectivities
were obtained in a reaction that required straightforward work-up
and puriﬁcation procedures [10].
2.5. Novel resins, linkers and techniques
A facile regio- and stereoselective synthesis of novel dispiro-
heterocyclic hybrids containing benzo[1,4]oxazine/benzo[1,4]thi-
azine and pyrrolidine/thiapyrrolizidine moieties has been carried
out. The reaction proceeds by a 1,3-dipolar cycloaddition and has
used 2,2,2-triﬂuoroethanol as a new alternative green solvent
and catalyst for rapid access to a diversity-oriented library of com-
pounds. Mild reaction conditions with excellent conversion, higher
yields in shorter reaction times and the easy recyclability of 2,2,2-
triﬂuoroethanol makes this protocol attractive, sustainable and
environmentally benign [11].
A unique method of ribosomally synthesising fused tricyclic
peptides has been described. Flexizyme-assisted in vitro translation
of a linear peptide with the N-terminal chloroacetyl group and four
downstream cysteines followed by the addition of 1,3,5-tris-
(bromomethyl)benzene results in selective production of the fused
tricyclic peptide structures. This technology can be used for the
ribosomal synthesis of fused tricyclic peptide libraries for the
in vitro selection of bioactive peptides with tricyclic topology [12].
2.6. Library applications
A library of novel 3-triﬂuoromethyl pyrazolo-1,2,3-triazole
hybrids have been obtained starting from 5-phenyl-3-(triﬂuo-
romethyl)-1H-pyrazol-4-amine via a key azido intermediate using
a click chemistry approach. The compounds obtained were evalu-
ated for in vitro antimycobacterial activity against Mycobacterium
smegmatis (MC2 155) and also veriﬁed for cytotoxicity. These
studies generated promising lead compounds with promising
antitubercular activity and low cytotoxicity against the A549
cancer cell line [13].
Meridianins are a group of marine-derived indole alkaloids
reported to possess kinase inhibitory activities. The synthesis of
N1-substituted and C-ring modiﬁed meridianin derivatives and
their evaluation as Dyrk1A inhibitors and neuroprotective agents
has been described. Among the library of 52 compounds screened,
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values of around 0.5 lM. One key compound was not cytotoxic
to human neuroblastoma SH-SY5Y cells (IC50 > 100 lM) and dis-
played signiﬁcant neuroprotection against glutamate-induced
neurotoxicity in these cells at 10 lM [14].
The alarming rise of extensively drug-resistant tuberculosis
(XDR-TB) strains, has compelled the development of new mole-
cules with novel modes of action to control this world health emer-
gency. Distamycin analogues containing N-terminal biaryl-motifs
have been synthesised using a solution-phase approach and evalu-
ated for their anti-mycobacterial activity and DNA-sequence selec-
tivity [15].
A library of novel 2,5-disubtituted-1,3,4-oxadiazoles with a
benzimidazole backbone have been synthesised and evaluated
for their potential as b-glucuronidase inhibitors. All the synthe-
sised compounds were characterised satisfactorily by using differ-
ent spectroscopic methods, and several showed excellent
inhibitory potentials [16].
A natural product inspired modular diversity-orientated syn-
thesis strategy for the synthesis of a library of hybrid systems that
are structurally and stereochemically disparate has been described.
The main scaffold is a pyrroloisoquinoline motif, synthesised by a
tandem Pictet–Spengler lactamisation. The structural diversity is
generated via ‘‘privileged scaffolds’’ that are attached at the appro-
priate site of the motif. Screening of the library compounds for
their antiplasmodial activity against chloroquine sensitive 3D7
cells indicated a few compounds with moderate activity (20–
50 lM) [17].
A small and structure-biased library of enantiopure anti-b-
amino alcohols has been prepared in a straightforward manner
by a simpliﬁed version of the Reetz protocol. Antiproliferative
activity testing against a panel of ﬁve human solid tumour cell
lines gave GI50 values in the range 1–20 lM. The reverse screening
by computational methods against 58 proteins involved in cancer
pointed to kinases as possible therapeutic target candidates, and
in particular the compounds were shown to behave as selective
CK1e inhibitors [18].
The preparation and cytotoxic properties of a small focused
library of lupane and 18a-oleanane triterpenoids, that contain a
combination of two structural motifs known to enhance biological
activities, has been described. First, two ﬂuorine atoms were intro-
duced to position 2 of the skeleton, and second, hemiester pro-
drugs were synthesised, which were intended to increase the
solubility and activity. Overall, 21 compounds were prepared, 11
of them new, and their cytotoxicity was tested on T lymphoblastic
leukemia CCRF-CEM cells and the most active derivatives were
selected for screening on another six tumour and two non-tumour
cell lines [19].References
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